Transcripts Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
18:03:32 18/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 3.185 USD | -1.09% |
|
+0.47% | +16.18% |
| 08-14 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
| 08-11 | Perspective Therapeutics's NET Program Data May Allow Phase 3 Trial Start, Value Inflection, RBC Says | MT |
Transcripts
Search
No results match your criteria
Select your edition
All financial news and data tailored to specific country editions
















